{
    "nct_id": "NCT03735095",
    "official_title": "Endobronchial Ultrasound Transbronchial Needle Guided Interstitial Photodynamic Therapy for Palliation of Locally Advanced Lung Cancer and Advanced Cancers Obstructing the Airway -Phase I/II",
    "inclusion_criteria": "* > 18 year olds\n* Eligibility checklist before registration requires review of case by study surgeon or interventional pulmonologists to approve anatomic feasibility of an airway intervention\n* For patients in Cohort B only. Patients are amenable to receive a palliative radiotherapy of 8 Gy x1 48Â±4 h prior to the I-PDT, as determined by the radiation oncologist\n* Patients with an established pathologic diagnosis of small cell and/or non-small cell lung cancer or other malignancies causing airway obstruction > 25% requiring bronchoscopic intervention. Or inoperable malignancies not candidates for curative radiotherapy within the airway.\n* Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 3\n* Platelets >= 100,000 cells/mm^3 (International System of Units [SI] units 100 x 10^9/L).\n* Participants of child-bearing potential must agree to use adequate contraceptive methods (e.g., hormonal or barrier method of birth control; abstinence) prior to study entry. Should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately.\n* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Participants who have had radiotherapy to the target tumor within 4 weeks prior to the scheduled I-PDT and/or PDT.\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Pregnant or nursing female participants.\n* Co-existing ophthalmic disease likely to require slit-lamp examination within 14 days following I-PDT and/or PDT treatment.\n* Known hypersensitivity/allergy to porphyrin.\n* Patients who are not cleared by the anesthesiologist to undergo an advanced bronchoscopy procedure under general anesthesia.\n* Patients with target tumor invading into the lumen of the esophagus, confirmed by esophago-gastro-duodenoscopy (EGD) with endoscopic ultrasound\n* Patients diagnosed with porphyria.\n* Unwilling or unable to follow protocol requirements.\n* Any condition which in the Investigator's opinion deems the participant an unsuitable candidate to receive I-PDT or PDT.",
    "miscellaneous_criteria": ""
}